(Q35116158)

6 August 2017

1 reference

title

Rotavirus vaccines--an update (English)

1 reference

6 August 2017

Rotavirus vaccines – an update (English)

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

28 December 2023

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

28 December 2023

1

Carl D Kirkwood

1 reference

6 August 2017

2

Jim Buttery

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14712598.3.1.97

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Expert Opinion on Biological Therapy

28 December 2023

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

97-105

1 reference

Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Characterization of human rotavirus serotype G9 isolated in Japan and Thailand from 1995 to 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Genetic and antigenic diversity of human rotaviruses: potential impact on the success of candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Seroepidemiologic Evaluation of Antibodies to Rotavirus as Correlates of the Risk of Clinically Significant Rotavirus Diarrhea in Rural Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Functional mapping of protective domains and epitopes in the rotavirus VP6 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Pathogenesis of rotavirus diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Rotavirus vaccines: development, current issues and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

A Rotavirus Vaccine for Prevention of Severe Diarrhoea of Infants and Young Children: Development, Utilization and Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Human rotavirus infection in infants and young children with intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

A two-part study of the aetiological role of rotavirus in lntussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Genetic analysis of Group A rotaviruses: evidence for interspecies transmission of rotavirus genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.97

Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis

28 December 2023

8

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

28 December 2023

Correspondence

9

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Characterisation of rotaviruses from children treated at a London hospital during 1996: Emergence of strainsG9P2A[6] and G3P2A[6]

28 December 2023

12

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Unusual diversity of human rotavirus G and P genotypes in India.

28 December 2023

13

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Detection and characterization of novel rotavirus strains in the United States.

28 December 2023

14

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Correlates of protection against rotavirus infection and disease.

28 December 2023

24

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Role of coproantibody in clinical protection of children during reinfection with rotavirus

28 December 2023

25

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

28 December 2023

30

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

28 December 2023

34

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique

28 December 2023

36

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus

28 December 2023

38

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Pathogenesis of rotavirus gastroenteritis

28 December 2023

39

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

28 December 2023

Rotavirus vaccines

44

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

28 December 2023

49

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

28 December 2023

52

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Early phase II trial of human rotavirus vaccine candidate RV3

28 December 2023

53

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

28 December 2023

54

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

28 December 2023

56

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2)

28 December 2023

58

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18

28 December 2023

59

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

28 December 2023

62

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles

28 December 2023

64

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

A one-year virological survey of acute lntussusception in childhood

28 December 2023

71

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.97

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference